Weight gain, improvements in metabolic profiles and immunogenicity with insulin or sulphonylurea administration in AIDS

Clinical Drug Investigation

Volumn 24, Issue 5, 2004, Pages 287-294

  Kabadi, Udaya M ^a,c   Kabadi, Mary U ^b  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; GLIPIZIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEGESTROL; SULFONYLUREA; TESTOSTERONE ENANTATE; TOCOPHEROL; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPOGLYCEMIA; IMMUNOGENICITY; LABORATORY TEST; MALE; METABOLISM; PRIORITY JOURNAL; STUDENT T TEST; URINALYSIS; WASTING SYNDROME; WEIGHT GAIN;

EID: 2542467059     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424050-00005     Document Type: Article

References (42)

1. Green JB. Clinical approach to weight loss in the patient with HIV infection. Gastroenterol Clin North Am 1988; 17: 573-86
2. Hellerstein MK, Kahn J, Mundie H, et al. Current approach to the treatment of human immunodeficiency virus-associated weight loss: pathophysiologic considerations and emerging strategies. Semin Oncol 1990; 17: 17-33
3. Kotler DP, Tierney AR, Ferraro R, et al. Enterai alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome. Am J Clin Nutr 1991; 3: 149-54
4. Suttmann U, Ockenga J, Hoogestraat L, et al. Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients. Metabolism 1993; 2: 1173-9
5. Kotler DP, Tierney AR, Wang J, et al. Effect of 14 home total parenteral nutrition upon body composition in AIDS. J Parenter Enterai Nutr 1990; 14 (5): 454-8
6. Kotler DP. Malnutrition in HIV infection and AIDS. AIDS 1989; 3 Suppl. 1: S175-80
7. Kaufman FR, Gomperts ED. Growth failure in boys with hemophilia and HIV infection. Am J Pediatr Hematol Oncol 1989; 11 (3): 292-4
8. Nunez EA, Christeff N. Steroid-hormone, cytokine, lipid and metabolic disturbances in HIV-infection. BaiIIieres Clin Endocrinol Metab 1994; 8 (4): 803-24
9. Kotler DP, Tierney AR, Francisco A, et al. The magnitude of body cell mass depletion determines the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444-7
10. Suttmann U, Muller MJ, Ockenga J, et al. Malnutrition and immune dysfunction in patients infected with human immunodeficiency virus. Klin Wochenschr 1991; 69: 156-62
11. Cunningham-Rundles S. Effects of nutritional status on immunological function. Am J Clin Nutr 1982; 35: 1202-10
12. Carbonnel F, Maslo C, Beaugerie L, et al. Effect of andinavir on HIV-related wasting. AIDS 1998; 12 (14): 1777-84
13. Sendi PP, Bucher HC, Craig BA, et al. Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20 (4): 376-81
14. Vandamme AM, Van Vaerenbergh K, DeClercq E. Anti-human immunodeficiency virus drug combination strategies. Antivir Chem Chemother 1998; 9 (3): 187-203
15. Suttmann U, Selberg O, Muller MJ, et al. Home enteral nutrition in patients with acquired immunodeficiency syndrome. Clin Nutr 1993; 12: 287-92
16. Selberg O, Suttmann U, Melzer A, et al. Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss. Metabolism 1995; 44 (9): 1159-65
17. Rabkin JG, Rabkin R. Mood and androgenic effects of testosterone in late-stage HIV illness. Psychosom Med 1995; 57 (1): 87-8
18. Rabkin JG, Rabkin R, Wagner G. Testosterone replacement therapy, in HIV illness. Gen Hosp Psychiatry 1995; 17 (1): 37-42
19. Graham KK, Mikolich DJ, Fisher AE, et al. Pharmacologic evaluation of megestrol acetate oral suspension in cachectic AIDS patients. J Acquir Immune Defic Syndr 1994; 7 (6): 580-6
20. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994; 121 (6): 393-9
21. Oster MH, Enders SR, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994; 121 (6): 400-8
22. Krentz AJ, Koster FT, Crist DM, et al. Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquir Immune Defic Syndr 1993; 6 (3): 245-51
23. Mulligan K, Grunfeld C, Hellerstein MK, et al. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993; 77 (4): 956-62
24. Lieberman SA, Butterfield GE, Harrison D, et al. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994; 78 (2): 404-10
25. Ellis KJ, Lee PD, Pivarnik JM, et al. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone. J Clin Endocrinol Metab 1996; 81 (8): 3033-8
26. Lee PD, Pivarnik JM, Bukar JG, et al. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1996; 81 (8): 2968-75
27. Hermans P, Clumeck N. Preliminary results on clinical and immunological effects of thymus hormone preparations in AIDS. Med Oncol Tumor Pharmacother 1989; 6 (1): 55-8
28. Berger JR, Pall L, Hall CD, et al. Oxandronlone in AIDS-wasting myopathy. AIDS 1996; 10 (14): 1657-62
29. Hengge UR, Baumann M, Maleba R, et al. Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr 1996; 75 (1): 129-38
30. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
31. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352 (9131): 854-65
32. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993; 341: 927-8
33. Ziegler A, Bachmann W, Rabl W. Prophylactic insulin treatment in relatives at high risk for type I diabetes. Diabetes Metab Rev 1993; 9: 289-93
34. American Diabetes Association. Association of type 1 diabetes mellitus. Diabetes Care 2000; 23 Suppl. 1: S108
35. Kabadi UM, Reust CS, Kabadi MU. Weight gain, improvement in metabolic profile, and CD4 count with insulin administration in an AIDS patient. AIDS Patient Care STDS 2000; 14: 575-9
36. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2001; 24 (S1): S5-20
37. Kabadi UM, O'Connell KM, Johnson J, et al. The effect of recurrent practice at home on the acceptability of capillary blood glucose readings. Diabetes Care 1994; 17 (10); 1110-4
38. Kabadi UM, Kabadi MU. Acceptability of capillary blood glucose testing with Companion 2 after intensive individual patient training. Diabetes Res 1994; 26: 25-32
39. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 19: 1359-67
40. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88 (3): 1082-8
41. Kabadi UM. Elevated glycosylated hemoglobin concentrations in AIDS. AIDS 1992; 6 (2): 236-8
42. Kabadi UM, Hood L. Increased glycation of hemoglobin in AIDS: relation to severity of the disorder. Diabetes Res 1998; 33: 37-44